The Effect of Infant Massage Applied at Different Durations on Comfort and Physiological Stability in Late Preterm Infants Receiving nCPAP

ConditionsNeonatalPreterm
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-1
SponsorTarsus University

About this trial

Aim: The aim of this study is to investigate the effects of massage administered for varying durations on comfort levels and physiological stability in late-preterm newborns receiving nCPAP. Method: The study will be conducted between Agust 2026 and June 2027 at the Neonatal Intensive Care Unit of Tarsus State Hospital with late preterm infants who will receive nCPAP therapy. Late preterm infants scheduled to receive nCPAP therapy (a total of 90 infants) will be divided into three groups (intervention group 1: 30; intervention group 2: 30; control group: 30). The pre-procedure comfort levels of all newborns will be assessed using the COMFORTneo Scale. In addition, the infants' heart rate, respiratory rate, oxygen saturation, and body temperature will be recorded. In addition to standard clinical procedures, newborns in the first intervention group will receive massage for 5 minutes twice daily for 3 days, in addition to routine clinical care. Newborns in the second intervention group will receive massage for 10 minutes twice daily for 3 days, in addition to routine clinical care. Newborns in the control group will not receive any additional intervention; only the clinic's routine care protocols will be followed.

After each massage session is completed, the newborns' comfort levels will be reassessed using the COMFORTneo Scale; heart rate, respiratory rate, oxygen saturation, and body temperature will be recorded. This procedure will be repeated for each session throughout the 3-day intervention period, and all measurements will be recorded on the follow-up form.

Eligibility criteria

Qualifiers

Be between 34⁰/₇ and 36⁶/₇ weeks of gestation,

Be receiving nCPAP support,

Be hemodynamically stable,

Have started enteral feeding,

Disqualifiers

Are receiving invasive mechanical ventilation,

Have undergone a surgical procedure,

Have a neurological disorder or a serious congenital anomaly,

Are receiving sedatives or neuromuscular blocking agents,

Trial design

Treatments tested in this trial

  • 1. İntervention group
  • 2. İntervention group

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators